Early Access — free while we kick the tires
EdgarHawk

Johnson Ashley F.

President & CFO

Officer

Latest: President & CFO selling · April 2026

2 filings analyzed · 1 company · Latest 2026-04-06

Companies

Company Buys Sells Direction
Planet Labs PBC PL 0 9 Net selling

Activity

April 2026
2026-04-06 Planet Labs PBC PL
high
Sell
200,000 shares
$7,020,219
Significance 6/10

CFO Johnson Ashley F. sold 200,000 shares (200.0K shares) for $7,020,218.58 ($7.0M) at Planet Labs across 2 transactions on 2026-04-02.

Johnson Ashley F., President & CFO of Planet Labs PBC, executed two separate sales totaling 200,000 shares for $7,020,218.58, reducing his holdings from 725.7K to 525.7K shares (-27.6%). The sales occurred at $34.76 and $35.22 per share, near the stock's current price of $35.02 and well above the 52-week low of $2.96, reflecting a recent 30-day rally of +38.5% and 90-day surge of +60.4%. The timing of this substantial divestiture—reducing stakes by more than one-quarter—follows the insider's prior two sales at this ticker on 2026-01-21, both of which showed negative 30-day returns (-11.6% and -11.5%). Planet Labs remains unprofitable (net income: $-59,185,000.00 for the latest quarter) despite 25.9% annual revenue growth, creating a disconnect between near-term stock momentum and underlying business fundamentals that warrants investor attention to the reasons behind this significant stake reduction.

January 2026
2026-01-22 Planet Labs PBC PL
high
Sell
150,731 shares
$4,071,803
Significance 6/10

President & CFO Johnson Ashley F. sold 150,731 shares at blended $27.01 for $4.1M; retains 1.96M shares post-sale

Johnson Ashley F., President & CFO of Planet Labs PBC, executed 2 separate sales totaling 150,731 shares for $4,071,803.22 on 2026-01-21 at a blended average price of $27.01. The sale reduces her holdings from 2,106,832 shares to 1,956,101 shares (a -7.2% reduction). This transaction occurs in a context where Planet Labs reported a net income of $-59,185,000.00 against quarterly revenue of $81,254,000.00, and the company remains unprofitable on a full-year basis despite annual revenue growth of +10.7%. The stock price on the transaction date ($27.01) sits 9.4% below the 52-week high of $28.78, having appreciated 25.7% over the prior 30 days and 91.5% over the prior 90 days. The scale and structure of this sale—two discrete transactions totaling over 150K shares at near-identical prices in a single day—warrants investor attention given the recent sharp price appreciation and the company's ongoing unprofitability.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access